AC
Agent Capital
Micro VCActiveA biotech venture capital firm.
14
Investments
4
Exits
$101M
AUM
28.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Agent Capital.
Investment Thesis & Strategy
Agent Capital invests in various stages of biotech companies, focusing on those with innovative technologies and the potential for significant impact on human health.
Investment Activity
Deals per year over the last 5 years
1
20172
20183
20191
20205
2021Portfolio Companies
Selected investments from their portfolio of 14 companies
K
Kyverna Therapeutics
Biotech · Series A, 2021
A
Affini-T Therapeutics
Biotech · Series A, 2021
V
Ventyx Biosciences
Biotech · Series B, 2021
D
Disc Medicine
Biotech · Series A, 2021
T
Tessera Therapeutics
Biotech · Series A, 2021
A
AavantiBio
Biotech · Series A, 2020
S
Sana Biotechnology
Biotech · Series A, 2019
V
Vor Biopharma
Biotech · Series A, 2019
X
Xilio Therapeutics
Biotech · Series A, 2019
G
Gyroscope Therapeutics
Biotech · Series A, 2018
C
Cabaletta Bio
Biotech · Series A, 2018
A
AlloVir
Biotech · Series B, 2017
Frequently Asked Questions
Agent Capital focuses on Seed, Series A stage investments.
Related Investors
Founder Collective
Cambridge, United States · 379 deals
Rough Draft Ventures
Cambridge, United States · 81 deals
Vestigo Ventures
Cambridge, United States · 20 deals
Blue Haven Initiative
Cambridge, United States · 18 deals
Link Ventures
Cambridge, United States · 16 deals
Castle Island Ventures
Cambridge, United States · 14 deals